Rang	Name	Position
1	Mr. Christopher A. Viehbacher	President, CEO & Director
2	Ms. Robin C. Kramer	Executive VP & CFO
3	Ms. Nicole Murphy	Executive VP and Head of Pharmaceutical Operations & Technology
4	Dr. Priya Singhal M.D., M.P.H.	Executive VP & Head of Development
5	Mr. Sean Godbout	VP, Chief Accounting Officer & Global Corporate Controller
6	Mr. Guy Hadari	Chief Information Officer
7	Mr. Tim Power M.B.A., Ph.D.	Head of Investor Relations
8	Mr. Michael John Parini J.D.	Chief Legal Officer
9	Ms. Natacha Gassenbach	Chief Communication Officer & Head of Corporate Affairs
10	Mr. Adam Keeney Ph.D.	Executive VP & Head of Corporate Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	10,81%	3,47 Mrd. USD
2	PRIMECAP Management Company	10,26%	3,29 Mrd. USD
3	FMR Inc	8,67%	2,78 Mrd. USD
4	Vanguard Capital Management, LLC	6,45%	2,07 Mrd. USD
5	State Street Corp	4,85%	1,56 Mrd. USD
6	Vanguard Portfolio Management, LLC	4,42%	1,42 Mrd. USD
7	Geode Capital Management, LLC	2,94%	0,94 Mrd. USD
8	Wellington Management Company LLP	2,11%	0,68 Mrd. USD
9	NORGES BANK	1,75%	0,56 Mrd. USD
10	Morgan Stanley - Brokerage Accounts	1,47%	0,47 Mrd. USD
11	JPMorgan Chase & Co	1,36%	0,44 Mrd. USD
12	AQR Capital Management LLC	1,30%	0,42 Mrd. USD
13	Amvescap Plc.	1,18%	0,38 Mrd. USD
14	Northern Trust Corp	0,98%	0,31 Mrd. USD
15	UBS Asset Mgmt Americas Inc	0,93%	0,30 Mrd. USD
16	Legal & General Group PLC	0,91%	0,29 Mrd. USD
17	Boston Partners Global Investors, Inc	0,86%	0,27 Mrd. USD
18	T. Rowe Price Investment Management,Inc.	0,79%	0,25 Mrd. USD
19	Bank of America Corp	0,78%	0,25 Mrd. USD
20	Charles Schwab Investment Management Inc	0,78%	0,25 Mrd. USD